🎉 M&A multiples are live!
Check it out!

Apeloa Pharmaceutical Valuation Multiples

Discover revenue and EBITDA valuation multiples for Apeloa Pharmaceutical and similar public comparables like Vivoryon Therapeutics, Julphar, and Galapagos.

Apeloa Pharmaceutical Overview

About Apeloa Pharmaceutical

Apeloa Pharmaceutical Co Ltd is a pharmaceutical company. It is engaged in research and development, manufacturing and marketing of APIs formulations and veterinary drugs. It offers products including Ofloxacin, Levofloxacin Hydrochloride, Marbofloxacin, and others.


Founded

1997

HQ

China
Employees

3.4K+

Website

apeloa.com

Financials

LTM Revenue $1.7B

LTM EBITDA $234M

EV

$1.9B

Valuation Multiples

Multiples.vc

Sign up to see

Valuation Multiples for 10K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Apeloa Pharmaceutical Financials

Apeloa Pharmaceutical has a last 12-month revenue of $1.7B and a last 12-month EBITDA of $234M.

In the most recent fiscal year, Apeloa Pharmaceutical achieved revenue of $1.7B and an EBITDA of $249M.

Apeloa Pharmaceutical expects next 12-month revenue of  XXX    and NTM EBITDA of  XXX

See Apeloa Pharmaceutical valuation multiples based on analyst estimates

Apeloa Pharmaceutical P&L

FY 2023 FY 2024 FY 2025 LTM NTM
Revenue $1.6B $1.7B XXX XXX XXX
Gross Profit $347M $406M XXX XXX XXX
Gross Margin 22% 24% XXX XXX XXX
EBITDA $247M $249M XXX XXX XXX
EBITDA Margin 16% 15% XXX XXX XXX
Net Profit $136M $145M XXX XXX XXX
Net Margin 9% 9% XXX XXX XXX
Net Debt n/a n/a XXX XXX XXX

Financial data powered by Morningstar, Inc.

Apeloa Pharmaceutical Stock Performance

As of April 15, 2025, Apeloa Pharmaceutical's stock price is CNY 14 (or $2).

Apeloa Pharmaceutical has current market cap of CNY 16.3B (or $2.2B), and EV of CNY 13.6B (or $1.9B).

See Apeloa Pharmaceutical trading valuation data

Apeloa Pharmaceutical Stock Data

EV Market Cap Price 1D Price 1M Price 3M Price 12M EPS
$1.9B $2.2B XXX XXX XXX XXX $0.13

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Sign Up

Apeloa Pharmaceutical Valuation Multiples

As of April 15, 2025, Apeloa Pharmaceutical has market cap of $2.2B and EV of $1.9B.

Apeloa Pharmaceutical's trades at 1.1x LTM EV/Revenue multiple, and 8.0x LTM EBITDA.

Analysts estimate Apeloa Pharmaceutical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See valuation multiples for Apeloa Pharmaceutical and 10K+ public comps

Apeloa Pharmaceutical Financial Valuation Multiples

FY 2024 FY 2025E FY 2026E FY 2027E
EV $1.9B XXX XXX XXX
EV/Revenue 1.1x XXX XXX XXX
EV/EBITDA 7.5x XXX XXX XXX
P/E 15.8x XXX XXX XXX
P/E/Growth 0.9x XXX XXX XXX
EV/FCF 18.2x XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Apeloa Pharmaceutical Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Sign Up

Apeloa Pharmaceutical Valuation Multiples

Apeloa Pharmaceutical's NTM/LTM revenue growth is 9%

Apeloa Pharmaceutical's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.1M for the same period.

Over next 12 months, Apeloa Pharmaceutical's ratio of sales and marketing spend to revenue is estimated to be  XXX , while its R&D spend to revenue to be  XXX .

Analysts estimate Apeloa Pharmaceutical's 2025E EV/Revenue multiple at  XXX and 2025E EV/EBITDA multiple at  XXX

See operational valuation multiples for Apeloa Pharmaceutical and other 10K+ public comps

Apeloa Pharmaceutical Operational Valuation Multiples

FY 2024 NTM FY 2025E FY 2026E FY 2027E
Revenue Growth 5% XXX XXX XXX XXX
EBITDA Margin 15% XXX XXX XXX XXX
EBITDA Growth 1% XXX XXX XXX XXX
Rule of 40 (SaaS-only) 25% XXX XXX XXX XXX
Revenue per Employee $0.5M XXX XXX XXX XXX
Opex per Employee $0.1M XXX XXX XXX XXX
S&M Expenses to Revenue 4% XXX XXX XXX XXX
G&A Expenses to Revenue 1% XXX XXX XXX XXX
R&D Expenses to Revenue 5% XXX XXX XXX XXX
Opex to Revenue 14% XXX XXX XXX XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics
Pharma Analytics
Private Equity
ERP Software
Developer Tools
Consumer SaaS
Streaming Platforms

Apeloa Pharmaceutical Public Comps

See public comps and valuation multiples for Drug Development & Therapeutics and Contract Research & Manufacturing comps
EV/Revenue EV/EBITDA
2025E 2026E 2027E 2025E 2026E 2027E
Julphar XXX XXX XXX XXX XXX XXX
Benevolent AI XXX XXX XXX XXX XXX XXX
Galapagos XXX XXX XXX XXX XXX XXX
Pharming XXX XXX XXX XXX XXX XXX
Vivoryon Therapeutics XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX
XXXXXXXX XXX XXX XXX XXX XXX XXX

Valuation data powered by FactSet, Inc.

Apeloa Pharmaceutical M&A and Investment Activity

Apeloa Pharmaceutical acquired  XXX companies to date.

Last acquisition by Apeloa Pharmaceutical was  XXXXXXXX, XXXXX XXXXX XXXXXX . Apeloa Pharmaceutical acquired  XXXXXXXX for  XXX (EV/Revenue multiple of  XXX ).

See M&A valuation multiples

Latest Acquisitions by Apeloa Pharmaceutical

Acquired Company EV EV/Revenue EV/EBITDA
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX
XXXXXXXXX XXX XXX XXX

Get Verified M&A Valuation Multiples

Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.

Sign Up

About Apeloa Pharmaceutical

When was Apeloa Pharmaceutical founded? Apeloa Pharmaceutical was founded in 1997.
Where is Apeloa Pharmaceutical headquartered? Apeloa Pharmaceutical is headquartered in China.
How many employees does Apeloa Pharmaceutical have? As of today, Apeloa Pharmaceutical has 3.4K+ employees.
Is Apeloa Pharmaceutical publicy listed? Yes, Apeloa Pharmaceutical is a public company listed on SHE.
What is the stock symbol of Apeloa Pharmaceutical? Apeloa Pharmaceutical trades under 000739 ticker.
When did Apeloa Pharmaceutical go public? Apeloa Pharmaceutical went public in 1997.
Who are competitors of Apeloa Pharmaceutical? Similar companies to Apeloa Pharmaceutical include e.g. Julphar, Benevolent AI, Galapagos, Pharming.
What is the current market cap of Apeloa Pharmaceutical? Apeloa Pharmaceutical's current market cap is $2.2B
What is the current revenue of Apeloa Pharmaceutical? Apeloa Pharmaceutical's last 12-month revenue is $1.7B.
What is the current EBITDA of Apeloa Pharmaceutical? Apeloa Pharmaceutical's last 12-month EBITDA is $234M.
What is the current EV/Revenue multiple of Apeloa Pharmaceutical? Current revenue multiple of Apeloa Pharmaceutical is 1.1x.
What is the current EV/EBITDA multiple of Apeloa Pharmaceutical? Current EBITDA multiple of Apeloa Pharmaceutical is 8.0x.
What is the current revenue growth of Apeloa Pharmaceutical? Apeloa Pharmaceutical revenue growth between 2023 and 2024 was 5%.
Is Apeloa Pharmaceutical profitable? Yes, Apeloa Pharmaceutical is EBITDA-positive (as of the last 12 months).

Join Now Or Talk To Us

Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.